Safety of infliximab: Primum non nocere

被引：5

作者：

Parsi, MA ^{[1
]}

Lashner, BA ^{[1
]}

机构：

[1] Cleveland Clin Educ Fdn, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA

来源：

INFLAMMATORY BOWEL DISEASES | 2004年 / 10卷 / 04期

关键词：

D O I：

10.1097/00054725-200407000-00028

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：486 / 487

页数：2

相关论文

共 9 条

[1]

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].

Baert, F ;

Noman, M ;

Vermeire, S ;

Van Assche, G ;

D'Haens, G ;

Carbonez, A ;

Rutgeerts, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608

[2]

The safety profile of infliximab in patients with Crohn's disease: The Mayo Clinic experience in 500 patients [J].

Colombel, JF ;

Loftus, EV ;

Tremaine, WJ ;

Egan, LJ ;

Harmsen, WS ;

Schleck, CD ;

Zinsmeister, AR ;

Sandborn, WJ .

GASTROENTEROLOGY, 2004, 126 (01) :19-31

[3]

Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial [J].

Farrell, RJ ;

Alsahli, M ;

Jeen, YT ;

Falchuk, KR ;

Peppercorn, MA ;

Michetti, P .

GASTROENTEROLOGY, 2003, 124 (04) :917-924

[4]

Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[5]

Kornbluth A, 1998, Inflamm Bowel Dis, V4, P328, DOI 10.1002/ibd.3780040415

[6]

Lim WS, 2002, NEW ENGL J MED, V346, P623

[7]

Infliximab for the treatment of fistulas in patients with Crohn's disease [J].

Present, DH ;

Rutgeerts, P ;

Targan, S ;

Hanauer, SB ;

Mayer, L ;

van Hogezand, RA ;

Podolsky, DK ;

Sands, BE ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

van Deventer, SJH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18) :1398-1405

[8]

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease [J].

Targan, SR ;

Hanauer, SB ;

vanDeventer, SJH ;

Mayer, L ;

Present, DH ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

Rutgeerts, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) :1029-1035

[9]

Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-α inhibitor [J].

Wagner, TE ;

Huseby, ES ;

Huseby, JS .

AMERICAN JOURNAL OF MEDICINE, 2002, 112 (01) :67-69